RR, Ciaraldi TP, Armstrong D, Burke P, Ligueros-Saylan M, Mudaliar S: Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers. J Clin Endocrinol Metab 2013;98:3446–3453.
37Chaves VE, Júnior FM, Bertolini GL: The metabolic effects of growth hormone in adipose tissue. Endocrine 2013;44:293–302.
38Stanley TL, Grinspoon SK: Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies. Growth Horm IGF Res 2015;25:59–65.
39Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP: Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins. Atherosclerosis 2000;153:491–498.
40Arosio M, Sartore G, Rossi CM, Casati G, Faglia G, Manzato E: LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicenter Octreotide Study Group. Atherosclerosis 2000;151:551–557.
41Vijayakumar A, Novosyadlyy R, Wu Y, Yakar S, Le-Roith D: Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm IGF Res 2010;20:1–7.
42Parkinson C, Drake WM, Wieringa G, Yates AP, Besser GM, Trainer PJ: Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly. Clin Endocrinol (Oxf) 2002;56:303–311.
43Hodish I, Barkan A: Long-term effects of pegvisomant in patients with acromegaly. Nat Clin Pract Endocrinol Metab 2008;4:324–332.
44Olefsky JM, Glass CK: Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219–246.
45Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Rev Immunol 2006;6:772–783.
46Olarescu NC, Ueland T, Godang K, Lindberg-Larsen R, Jørgensen JO, Bollerslev J: Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities. Eur J Endocrinol 2013;170:39–48.
47Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM: Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001;16;288:1102–1107.
48Fernández-Real JM, López-Bermejo A, Casamitjana R, Ricart W: Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 2003;88:2714–2718.
49Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459–469.
50Ronchi CL, Corbetta S, Cappiello V, Morpurgo PS, Giavoli C, Beck-Peccoz P, Arosio M, Spada A: Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients. Eur J Endocrinol 2004;150:663–669.
51Ciresi A, Amato MC, Pizzolanti G, Giordano Galluzzo C: Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. J Clin Endocrinol Metab 2012;97:2907–2915.
52Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003;149:331–335.
53Reyes-Vidal CM, Mojahed H, Shen W, Jin Z, Arias-Mendoza F, Fernandez JC, Gallagher D, Bruce JN, Post KD, Freda PU: Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment. J Clin Endocrinol Metab 2015;100:2946–2955.
Prof. Moises Mercado
Experimental Endocrinology Unit and Endocrinology Service
Sur 132, No. 142, Suite 210
Col. Las Américas, Mexico City 01120 (Mexico)
E-Mail moises.mercado@endocrinología.org.mx
Конец ознакомительного фрагмента.
Текст предоставлен ООО «ЛитРес».
Прочитайте эту книгу целиком, купив полную легальную версию на ЛитРес.
Безопасно оплатить книгу можно банковской картой Visa, MasterCard, Maestro, со счета мобильного телефона, с платежного терминала, в салоне МТС или Связной, через PayPal, WebMoney, Яндекс.Деньги, QIWI Кошелек, бонусными картами или другим удобным Вам способом.
